From the evidence provided, it can be suggested that the activation of specific PLC isozymes by norepinephrine is an important aspect of the signal transduction cascade that stimulates abnormal cardiomyocyte growth and that this pathway may constitute a sequence of cyclical actions that allow for the continuation of cardiac hypertrophy (Figure 2). Here, HSPG2 is linked to cardiac hypertrophy.